These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 21292255)
1. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Sönmezer M; Türkçüoğlu I; Coşkun U; Oktay K Fertil Steril; 2011 May; 95(6):2125.e9-11. PubMed ID: 21292255 [TBL] [Abstract][Full Text] [Related]
2. Fertility preservation in women with endometriosis: Oocyte cryopreservation and other techniques. Gazzo I; Moffa F; Ferrero S Best Pract Res Clin Obstet Gynaecol; 2024 Jul; 95():102503. PubMed ID: 38777734 [TBL] [Abstract][Full Text] [Related]
4. Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature. Keskin U; Ercan CM; Yilmaz A; Babacan A; Korkmaz C; Duru NK; Ergun A J Pak Med Assoc; 2014 Jul; 64(7):830-2. PubMed ID: 25255597 [TBL] [Abstract][Full Text] [Related]
6. Challenges and considerations in optimizing ovarian stimulation protocols in oncofertility patients. Coyne K; Purdy M; O'Leary K; Yaklic JL; Lindheim SR; Appiah LA Front Public Health; 2014; 2():246. PubMed ID: 25538933 [TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Franik S; Kremer JA; Nelen WL; Farquhar C Cochrane Database Syst Rev; 2014 Feb; (2):CD010287. PubMed ID: 24563180 [TBL] [Abstract][Full Text] [Related]
8. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy. Danis RB; Pereira N; Elias RT Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354 [TBL] [Abstract][Full Text] [Related]
9. How effective are the non-conventional ovarian stimulation protocols in ART? A systematic review and meta-analysis. Glujovsky D; Pesce R; Miguens M; Sueldo CE; Lattes K; Ciapponi A J Assist Reprod Genet; 2020 Dec; 37(12):2913-2928. PubMed ID: 33219862 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of random-start controlled ovarian stimulation in cancer patients. Kim JH; Kim SK; Lee HJ; Lee JR; Jee BC; Suh CS; Kim SH J Korean Med Sci; 2015 Mar; 30(3):290-5. PubMed ID: 25729252 [TBL] [Abstract][Full Text] [Related]
11. Ovarian stimulation in the luteal phase: systematic review and meta-analysis. Boots CE; Meister M; Cooper AR; Hardi A; Jungheim ES J Assist Reprod Genet; 2016 Aug; 33(8):971-80. PubMed ID: 27146151 [TBL] [Abstract][Full Text] [Related]
12. Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations. von Wolff M; Capp E; Jauckus J; Strowitzki T; Germeyer A; Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():146-9. PubMed ID: 26927896 [TBL] [Abstract][Full Text] [Related]
13. Fertility preservation options in breast cancer patients. Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157 [TBL] [Abstract][Full Text] [Related]
14. Ovarian stimulation for emergency fertility preservation in cancer patients: A case series study. Rashidi BH; Tehrani ES; Ghaffari F Gynecol Oncol Rep; 2014 Dec; 10():19-21. PubMed ID: 26075995 [TBL] [Abstract][Full Text] [Related]
15. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646 [TBL] [Abstract][Full Text] [Related]
16. Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation. Nayak SR; Wakim AN Fertil Steril; 2011 Jul; 96(1):e51-4. PubMed ID: 21601193 [TBL] [Abstract][Full Text] [Related]
17. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356 [TBL] [Abstract][Full Text] [Related]
18. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients. Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617 [TBL] [Abstract][Full Text] [Related]
19. Fertility after breast cancer treatment. Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568 [TBL] [Abstract][Full Text] [Related]
20. A review of the physiology behind letrozole applications in infertility: are current protocols optimal? Rose BI; Brown SE J Assist Reprod Genet; 2020 Sep; 37(9):2093-2104. PubMed ID: 32712844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]